DE60234097D1 - Chimere proteine zum targeting von zellen und der induktion von apoptose, und verfahren zu deren verwendung - Google Patents

Chimere proteine zum targeting von zellen und der induktion von apoptose, und verfahren zu deren verwendung

Info

Publication number
DE60234097D1
DE60234097D1 DE60234097T DE60234097T DE60234097D1 DE 60234097 D1 DE60234097 D1 DE 60234097D1 DE 60234097 T DE60234097 T DE 60234097T DE 60234097 T DE60234097 T DE 60234097T DE 60234097 D1 DE60234097 D1 DE 60234097D1
Authority
DE
Germany
Prior art keywords
apoptosis
induction
chimeric proteins
targeting cells
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60234097T
Other languages
English (en)
Inventor
David B Weiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Application granted granted Critical
Publication of DE60234097D1 publication Critical patent/DE60234097D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747Apoptosis related proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
DE60234097T 2001-05-25 2002-05-28 Chimere proteine zum targeting von zellen und der induktion von apoptose, und verfahren zu deren verwendung Expired - Fee Related DE60234097D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29379401P 2001-05-25 2001-05-25
PCT/US2002/016680 WO2002097042A2 (en) 2001-05-25 2002-05-28 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same

Publications (1)

Publication Number Publication Date
DE60234097D1 true DE60234097D1 (de) 2009-12-03

Family

ID=23130607

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60234097T Expired - Fee Related DE60234097D1 (de) 2001-05-25 2002-05-28 Chimere proteine zum targeting von zellen und der induktion von apoptose, und verfahren zu deren verwendung

Country Status (10)

Country Link
US (1) US7592012B2 (de)
EP (1) EP1397386B1 (de)
JP (1) JP2004535415A (de)
KR (1) KR20040014528A (de)
CN (1) CN100497387C (de)
AT (1) ATE446316T1 (de)
AU (1) AU2002314814B2 (de)
CA (1) CA2448100A1 (de)
DE (1) DE60234097D1 (de)
WO (1) WO2002097042A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050074865A1 (en) * 2002-08-27 2005-04-07 Compound Therapeutics, Inc. Adzymes and uses thereof
AU2006347606B2 (en) * 2005-09-09 2012-10-11 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for inhibiting cell death or enhancing cell proliferation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910486A (en) * 1994-09-06 1999-06-08 Uab Research Foundation Methods for modulating protein function in cells using, intracellular antibody homologues
AU5965296A (en) * 1995-05-31 1996-12-18 Regents Of The University Of Minnesota Recombinant polypeptide cytotoxins for cancer treatment
US6645490B2 (en) * 1998-03-02 2003-11-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Chimeric proteins with cell-targeting specificity and apoptosis-inducing activities
AU2185199A (en) * 1998-09-30 2000-04-17 Yoko Aida Apoptosis inducers
US6733994B2 (en) * 2000-10-04 2004-05-11 The Trustees Of The University Of Pennsylvania Highly expressible genes
US20040028651A1 (en) 2001-03-29 2004-02-12 Karrupiah Muthumani Composition and methods of using hiv vpr

Also Published As

Publication number Publication date
EP1397386A4 (de) 2005-01-05
KR20040014528A (ko) 2004-02-14
WO2002097042A2 (en) 2002-12-05
ATE446316T1 (de) 2009-11-15
EP1397386B1 (de) 2009-10-21
CN100497387C (zh) 2009-06-10
AU2002314814B2 (en) 2007-12-20
WO2002097042A3 (en) 2003-10-23
JP2004535415A (ja) 2004-11-25
US7592012B2 (en) 2009-09-22
CN1531552A (zh) 2004-09-22
EP1397386A2 (de) 2004-03-17
CA2448100A1 (en) 2002-12-05
US20040181041A1 (en) 2004-09-16

Similar Documents

Publication Publication Date Title
AU2018273986A1 (en) Bipartite base editor (BBE) architectures and type-II-C-Cas9 zinc finger editing
WO2019139645A3 (en) High efficiency base editors comprising gam
ATE380878T1 (de) Verfahren und zusammensetzungen für die proteinexpression und reinigung
DE60325892D1 (de) Stellungs- und verwendungsverfahren
NZ521396A (en) Fusion proteins comprising two or more Neisseria polypeptides
NO331271B1 (no) Fusjonsprotein for sekresjon av et protein av interesse til supernatanten til en bakteriekultur, fremgangsmate, plasmid og vertscelle for fremstilling
DE602005026855D1 (de) Vorrichtungen und verfahren zur bestimmung von proteaseaktivität
ATE525395T1 (de) Fusions proteine von glp-1-analoga
ATE517914T1 (de) Dimere fusionsproteine und materialien und verfahren zu deren herstellung
NO20025402D0 (no) Modifiserte ES-celler og ES-spesifikt gen
TW200607505A (en) Fused heterocyclic kinase inhibitors
DK2287288T3 (da) Medium frit for animalsk protein til dyrkning af celler
ATE510023T1 (de) Enzyme mit alpha-amylase-aktivität und verfahren zu deren verwendung
WO2005003313A8 (en) Methods and compositions for enhanced protein expression and purification
DK1641483T3 (da) Fusionsproteiner
DE602006021520D1 (de) Rekombinante Polypeptide auf Triplex-Gerüst-Basis
ATE457355T1 (de) Verfahren und dna-konstrukte zur produktion von polypeptiden mit hoher ausbeute
DE602004026912D1 (de) Formulierungen und verfahren zum denaturieren von proteinen
DE60230456D1 (de) Faktor-viii-polypeptide auf hohem expressionsnivea und verwendungsverfahren
WO2003097810A3 (en) Nitrilases, nucleic acids encoding them and methods for making and using them
WO2002022662A3 (en) Insect inhibitory bacillus thuringiensis proteins, fusions, and methods of use therefor
DE60139544D1 (de) Veränderte, fluoreszierende proteine
NO20083609L (no) Fremgangsmater og sammensetninger for malrettet-RELT
ATE466874T1 (de) Mit scytovirin der domäne 1 verwandte polypeptide
DK0981601T3 (da) Fremgangsmåder til dyrkning af celler og opformering af vira

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee